RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Popular articles
Trending New ÒÁÈ˾þà articles
1
The world's fastest spider tops 3.5 metres per second
2
Babies are born with the neural foundations for maths
3
We’ve uncovered a master gene that switches on human development
4
Our verdict on The Selfish Gene: An unpopular piece of popular science
5
This physicist is hunting for the biggest black hole in the universe
6
Humans sleep the least of all apes – is it the secret to our success?
7
Where, when and how to watch the 2026 solar eclipse
8
US government wants to have a useful quantum computer by 2028
9
The best sci-fi novel in 2026 so far – plus 6 other great reads
10
If you aren't terrified by this heatwave, you should be
